AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...
AbbVie sues HHS over Botox Medicare pricing, challenging CMS authority under the Inflation Reduction Act and drug price negotiation rules.
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming ...
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus type 1 infection.
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles. ‘Melania’ ...
A teen getting Botox should be a record scratch. Instead, it’s becoming normal. This isn’t a medical story that wandered onto the internet. It’s an ... Read More ...